Clinical Trial Update: A Study Of Deoxycoformycin(DCF)/Pentostatin In Lymphoid Malignancies [Phase 2]

View source ↗

Summary

Phase 2 trial of Deoxycoformycin (pentostatin) in lymphoid malignancies completed, studying Peripheral T-cell Lymphoma and Cutaneous T-cell Lymphoma. Chronic Ly…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Cutaneous T-cell Lymphoma
• Peripheral T-cell Lymphoma

Drugs mentioned

• Deoxycoformycin (pentostatin)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Peripheral T-cell Lymphoma, Cutaneous T-cell Lymphoma | Phase 2 | Status: COMPLETED